We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Committee Votes to Combine Bladder Pain, Interstitial Cystitis Patients in Trials
FDA Committee Votes to Combine Bladder Pain, Interstitial Cystitis Patients in Trials
An FDA advisory committee voted unanimously in favor of combining patients with bladder pain syndrome and interstitial cystitis in clinical trials citing the minimal differences in symptoms between the two populations.